These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31357981)

  • 1. The impact of screening on the survival of colorectal cancer in Shanghai, China: a population based study.
    Li X; Zhou Y; Luo Z; Gu Y; Chen Y; Yang C; Wang J; Xiao S; Sun Q; Qian M; Zhao G
    BMC Public Health; 2019 Jul; 19(1):1016. PubMed ID: 31357981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Compliance rate of screening colonoscopy and its associated factors among high-risk populations of colorectal cancer in urban China].
    Chen HD; Li N; Ren JS; Shi JF; Zhang YM; Zou SM; Zheng ZX; Zhang K; Dai M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):231-237. PubMed ID: 29973000
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
    Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
    JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results and cost-effectiveness of colorectal cancer screening program among urban residents in Zhejiang province, 2013-2018].
    Wang L; Li HZ; Zhu C; Wang YQ; Zhou HJ; Sun XH; Zhang MZ; Jin L; Du LB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2080-2086. PubMed ID: 33378820
    [No Abstract]   [Full Text] [Related]  

  • 5. The Implementation and First-Round Results of a Community-Based Colorectal Cancer Screening Program in Shanghai, China.
    Gong Y; Peng P; Bao P; Zhong W; Shi Y; Gu K; Zheng Y; Wu C; Cai S; Xu Y; Sheng J; Wu F
    Oncologist; 2018 Aug; 23(8):928-935. PubMed ID: 29540604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How spatial accessibility to colonoscopy affects diagnostic adherences and adverse intestinal outcomes among the patients with positive preliminary screening findings.
    Chen W; Zhang W; Liu H; Liang Y; Zhou Q; Li Y; Gu J
    Cancer Med; 2020 Jun; 9(12):4405-4419. PubMed ID: 32319229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of a short message service intervention to motivate people with positive results in preliminary colorectal cancer screening to undergo colonoscopy: A randomized controlled trial.
    Wu Y; Liang Y; Zhou Q; Liu H; Lin G; Cai W; Li Y; Gu J
    Cancer; 2019 Jul; 125(13):2252-2261. PubMed ID: 30825395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
    Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
    World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated With Colonoscopy Compliance Based on Health Belief Model in a Community-Based Colorectal Cancer Screening Program Shanghai, China.
    He L; Gao S; Tao S; Li W; Du J; Ji Y; Wang Y
    Int Q Community Health Educ; 2020 Oct; 41(1):25-33. PubMed ID: 31876256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time Trends in the Diagnosis of Colorectal Cancer With Obstruction, Perforation, and Emergency Admission After the Introduction of Population-Based Organized Screening.
    Decker KM; Lambert P; Nugent Z; Biswanger N; Samadder J; Singh H
    JAMA Netw Open; 2020 May; 3(5):e205741. PubMed ID: 32453385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study.
    Samadder NJ; Curtin K; Tuohy TM; Pappas L; Boucher K; Provenzale D; Rowe KG; Mineau GP; Smith K; Pimentel R; Kirchhoff AC; Burt RW
    Gastroenterology; 2014 Apr; 146(4):950-60. PubMed ID: 24417818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The performance of a community-based colorectal cancer screening program: Evidence from Shanghai Pudong New Area, China.
    Li X; Qian M; Zhao G; Yang C; Bao P; Chen Y; Zhou X; Yan B; Wang Y; Zhang J; Sun Q
    Prev Med; 2019 Jan; 118():243-250. PubMed ID: 30412744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation and yield of a population-based colorectal cancer screening programme in China.
    Chen H; Li N; Ren J; Feng X; Lyu Z; Wei L; Li X; Guo L; Zheng Z; Zou S; Zhang Y; Li J; Zhang K; Chen W; Dai M; He J;
    Gut; 2019 Aug; 68(8):1450-1457. PubMed ID: 30377193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of patients with symptom- and screening-detected colorectal cancer.
    Brenner H; Jansen L; Ulrich A; Chang-Claude J; Hoffmeister M
    Oncotarget; 2016 Jul; 7(28):44695-44704. PubMed ID: 27213584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah.
    Samadder NJ; Curtin K; Tuohy TM; Rowe KG; Mineau GP; Smith KR; Pimentel R; Wong J; Boucher K; Burt RW
    Gastroenterology; 2014 Oct; 147(4):814-821.e5; quiz e15-6. PubMed ID: 25042087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of primary care physician counseling on participation rate and use of sedation in colonoscopy-based colorectal cancer screening program--a randomized controlled study.
    Boguradzka A; Wiszniewski M; Kaminski MF; Kraszewska E; Mazurczak-Pluta T; Rzewuska D; Ptasinski A; Regula J
    Scand J Gastroenterol; 2014 Jul; 49(7):878-84. PubMed ID: 24797871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study.
    Erichsen R; Baron JA; Stoffel EM; Laurberg S; Sandler RS; Sørensen HT
    Am J Gastroenterol; 2013 Aug; 108(8):1332-40. PubMed ID: 23774154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival rates and predictors of survival among colorectal cancer patients in a Malaysian tertiary hospital.
    Magaji BA; Moy FM; Roslani AC; Law CW
    BMC Cancer; 2017 May; 17(1):339. PubMed ID: 28521746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interval colorectal cancer rates after Hemoccult Sensa and survival by detection mode for individuals diagnosed with colorectal cancer in Winnipeg, Manitoba.
    Decker KM; Nugent Z; Lambert P; Biswanger N; Singh H
    PLoS One; 2018; 13(9):e0203321. PubMed ID: 30180176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.